CN100531767C - Capsules for treating prostatauxe - Google Patents
Capsules for treating prostatauxe Download PDFInfo
- Publication number
- CN100531767C CN100531767C CNB200610047077XA CN200610047077A CN100531767C CN 100531767 C CN100531767 C CN 100531767C CN B200610047077X A CNB200610047077X A CN B200610047077XA CN 200610047077 A CN200610047077 A CN 200610047077A CN 100531767 C CN100531767 C CN 100531767C
- Authority
- CN
- China
- Prior art keywords
- grams
- capsule
- treatment
- major ingredient
- prostate hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of capsule for treating prostato megaly is prepared from 7-9 Chinese-medicinal materials including musk, fennel, pilose antler, cordyceps, etc through pulverizing, sieving and loading in capsules.
Description
Technical field:
The present invention relates to a kind of Chinese medicinal capsule, particularly a kind of capsule that is mainly used in the treatment prostate hyperplasia belongs to Chinese medicine preparation.
Background technology:
In the prior art, the treatment prostatosis adopts injection intravenous drip, Chinese medicine decoction, suppository etc. mostly.It is big to exist dosage, uses inconvenience, and some medicine has the shortcoming of damage to liver, kidney.
Summary of the invention:
The objective of the invention is at above-mentioned the deficiencies in the prior art, and provide a kind of, reach by oral way easily and cure the disease and the diseases prevention purpose by plurality of Chinese composition compatibility, and the capsule of the treatment prostate hyperplasia that has no side effect.For achieving the above object, the present invention adopts following technical proposals: a kind of capsule for the treatment of prostate hyperplasia, and it is mainly by following major ingredient weight share preparation, Moschus 1-3 part; Fructus Foeniculi 2-5 part; Cornu Cervi Pantotrichum 2-7 part; Cordyceps 3-7 part; Stigma Croci 3-7 part; Herba Saussureae Involueratae 3-7 part; Succinum 3-7 part.In above-mentioned composition, also can add Rhizoma Dioscoreae 3-7 part; Radix Notoginseng 3-7 part, its effect is better.
Removing above-mentioned major ingredient also needs the adjuvant capsule to make carrier, and concrete compound method is: above-mentioned all medicines are crushed to 200 order smalls at normal temperatures and pressures, and it is standby to reinstall No. 0 capsule.
The pharmacology of above-mentioned each component and effect: (1) Moschus dredge the meridian passage, blood circulation promoting and blood stasis dispelling; (2) the Fructus Foeniculi temperature is virtuous supporing yang; (3) Cornu Cervi Pantotrichum kidney invigorating and YANG supporting; (4) aweto nourishing lung kidney, raise immunity; (5) Stigma Croci invigorate blood circulation, acupuncture-stimulating blood stasis dispersing; (6) Herba Saussureae Involueratae clearing away heat and eliminating dampness, detoxifcation; (7) succinum inducing diuresis for treating stranguria syndrome; (8) Rhizoma Dioscoreae temperature compensation liver,spleen,kidney is dirty; (9) pseudo-ginseng blood-circulation-invigovating stasis-dispelling and pain-killing.
The present invention sums up on secular clinical practice experiential basis, has treatment and health care double effects.Its characteristics are: scientific formulation is reasonable, has both met reason, method, side, the medicine of the traditional Chinese medical science, has the modern medicine pharmacology to be foundation again, has kidney invigorating and YANG supporting, and sperm adding and marrow healthing strengthens kidney qi, promoting blood circulation to remove blood stasis, multiple efficacies such as hard masses softening and resolving.The administrated method science is easy, and by oral, stomach, intestinal digestion absorb, and have no side effect.Through taking the present invention to prostatic hyperplasia, the clinical effectiveness of impotence is obvious, and effective percentage can reach more than 95%; Obvious effective rate can reach more than 85%.
The specific embodiment:
Embodiment 1
A kind of capsule for the treatment of prostate hyperplasia, mainly by following major ingredient preparation, Moschus 10 restrains for it; Fructus Foeniculi 20 grams; Cornu Cervi Pantotrichum 20 grams; Cordyceps 30 grams; Stigma Croci 30 grams; Herba Saussureae Involueratae 30 grams; Succinum 30 grams.
Concrete compound method is: above-mentioned all medicines are crushed to 200 order smalls at normal temperatures and pressures, and pack into No. 0 capsule and bottling, 100 every bottle, each 5, early, noon, evening take.
Embodiment 2
A kind of capsule for the treatment of prostate hyperplasia, mainly by following major ingredient preparation, Moschus 30 restrains for it; Fructus Foeniculi 50 grams; Cornu Cervi Pantotrichum 70 grams; Cordyceps 70 grams; Stigma Croci 70 grams; Herba Saussureae Involueratae 70 grams; Succinum 70 grams.
Compound method and administrated method are identical with embodiment 1.
Embodiment 3
A kind of capsule for the treatment of prostate hyperplasia, mainly by following major ingredient preparation, Moschus 15 restrains for it; Fructus Foeniculi 35 grams; Cornu Cervi Pantotrichum 40 grams; Cordyceps 50 grams; Stigma Croci 45 grams; Herba Saussureae Involueratae 50 grams; Succinum 55 grams.
Compound method and administrated method are identical with embodiment 1.
Embodiment 4
A kind of capsule for the treatment of prostate hyperplasia, mainly by following major ingredient preparation, Moschus 20 restrains for it; Fructus Foeniculi 45 grams; Cornu Cervi Pantotrichum 35 grams; Cordyceps 45 grams; Stigma Croci 55 grams; Herba Saussureae Involueratae 65 grams; Succinum 45 grams.
Compound method and administrated method are identical with embodiment 1.
Embodiment 5
A kind of capsule for the treatment of prostate hyperplasia, mainly by following major ingredient preparation, Moschus 25 restrains for it; Fructus Foeniculi 30 grams; Cornu Cervi Pantotrichum 50 grams; Cordyceps 65 grams; Stigma Croci 55 grams; Herba Saussureae Involueratae 40 grams; Succinum 45 grams.
Compound method and administrated method are identical with embodiment 1.
Embodiment 6
A kind of capsule for the treatment of prostate hyperplasia, mainly by following major ingredient preparation, Moschus 28 restrains for it; Fructus Foeniculi 48 grams; Cornu Cervi Pantotrichum 60 grams; Cordyceps 55 grams; Stigma Croci 45 grams; Herba Saussureae Involueratae 68 grams; Succinum 50 grams.
Compound method and administrated method are identical with embodiment 1.
Embodiment 7
In the composition of embodiment 4, also can add Rhizoma Dioscoreae 30 grams; Radix Notoginseng 30 grams, compound method and administrated method are identical with embodiment 1.
Embodiment 8
In the composition of embodiment 5, also can add Rhizoma Dioscoreae 70 grams; Radix Notoginseng 70 grams, compound method and administrated method are identical with embodiment 1.
Embodiment 9
In the composition of embodiment 6, also can add Rhizoma Dioscoreae 40 grams; Radix Notoginseng 50 grams, compound method and administrated method are identical with embodiment 1.
Clinical case:
1, bent certain 77 years old address of man: Anshan
Suffer from prostatic hyperplasia 9 years (making a definite diagnosis in Anshan City Central Hospital), the state of an illness is more and more heavier, has urine to wait for lower abdominal distention pain, frequent micturition, symptoms such as urgent micturition.Night urination 7-8 time has a strong impact on sleep, waist soreness at ordinary times, and lassitude is had a dizzy spell.Take the present invention and treat, each 5, three times on the one.
Treated 10 days for the first time, conscious spirit takes a turn for the better, and dizzy, the soreness of waist alleviates night urination 4 times.Treated 10 days for the second time, all diseases all alleviate, and treat for the third time after 3 days, and night urination is unobstructed, only urinates once, no soreness of waist dizziness, and defecation is normal, and mental symptom is good, no any discomfort.
2,80 years old address of marquis man: Liaoyang City
Year surplus the trouble prostatic hyperplasia 20, soreness of waist lumbago, the perineum humidity, dyskoimesis, the whole body is unable, and nocturia number of times 10 times more than was once taken a large amount of Western medicine, Chinese medicine decoction etc., symptom is not alleviated.On May 10th, 2005 began to take the present invention, took that symptom obviously alleviates after 7 days, and stomachache disappears substantially, nocturia 3 times, and I am very satisfied.All are normal after taking medicine 20 days.
3, the Zhang man is 60 years old
This patient suffers from sexual impotence for many years, suffers from prostatic hyperplasia in the recent period again, once removes several families hospital therapy, and effect is undesirable.Take the present invention on October 11st, 2005, the pain of urinating after 5 days situation obviously alleviates, and the sexual impotence symptom is clearly better in the time of 10 days, and is approaching normal after 30 days.
Concrete clinical case history statistics sees the following form
Claims (10)
1, a kind of capsule for the treatment of prostate hyperplasia is made up of major ingredient and adjuvant, and adjuvant is a capsule, it is characterized in that described major ingredient comprises the component of following weight quota: Moschus 1-3 part; Fructus Foeniculi 2-5 part; Cornu Cervi Pantotrichum 2-7 part; Cordyceps 3-7 part; Stigma Croci 3-7 part; Herba Saussureae Involueratae 3-7 part; Succinum 3-7 part.
2, a kind of capsule for the treatment of prostate hyperplasia according to claim 1 is characterized in that also can adding in the described major ingredient Rhizoma Dioscoreae 3-7 part of weight share proportioning; Radix Notoginseng 3-7 part.
3, a kind of capsule for the treatment of prostate hyperplasia according to claim 1 is characterized in that the concrete consumption of described major ingredient: Moschus 10 grams; Fructus Foeniculi 20 grams; Cornu Cervi Pantotrichum 20 grams; Cordyceps 30 grams; Stigma Croci 30 grams; Herba Saussureae Involueratae 30 grams; Succinum 30 grams.
4, a kind of capsule for the treatment of prostate hyperplasia according to claim 1 is characterized in that the concrete consumption of described major ingredient: Moschus 30 grams; Fructus Foeniculi 50 grams; Cornu Cervi Pantotrichum 70 grams; Cordyceps 70 grams; Stigma Croci 70 grams; Herba Saussureae Involueratae 70 grams; Succinum 70 grams.
5, a kind of capsule for the treatment of prostate hyperplasia according to claim 1 is characterized in that the concrete consumption of described major ingredient: Moschus 15 grams; Fructus Foeniculi 35 grams; Cornu Cervi Pantotrichum 40 grams; Cordyceps 50 grams; Stigma Croci 45 grams; Herba Saussureae Involueratae 50 grams; Succinum 55 grams.
6, a kind of capsule for the treatment of prostate hyperplasia according to claim 1 is characterized in that the concrete consumption of described major ingredient: Moschus 25 grams; Fructus Foeniculi 30 grams; Cornu Cervi Pantotrichum 50 grams; Cordyceps 65 grams; Stigma Croci 55 grams; Herba Saussureae Involueratae 40 grams; Succinum 45 grams.
7, a kind of capsule for the treatment of prostate hyperplasia according to claim 1 is characterized in that the concrete consumption of described major ingredient: Moschus 28 grams; Fructus Foeniculi 48 grams; Cornu Cervi Pantotrichum 60 grams; Cordyceps 55 grams; Stigma Croci 45 grams; Herba Saussureae Involueratae 68 grams; Succinum 50 grams.
8, a kind of capsule for the treatment of prostate hyperplasia according to claim 2 is characterized in that adding in the described major ingredient Rhizoma Dioscoreae 30 grams, Radix Notoginseng 30 grams.
9, a kind of capsule for the treatment of prostate hyperplasia according to claim 2 is characterized in that adding in the described major ingredient Rhizoma Dioscoreae 70 grams, Radix Notoginseng 70 grams.
10, a kind of capsule for the treatment of prostate hyperplasia according to claim 2 is characterized in that adding in the described major ingredient Rhizoma Dioscoreae 40 grams, Radix Notoginseng 50 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610047077XA CN100531767C (en) | 2006-06-29 | 2006-06-29 | Capsules for treating prostatauxe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610047077XA CN100531767C (en) | 2006-06-29 | 2006-06-29 | Capsules for treating prostatauxe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1895474A CN1895474A (en) | 2007-01-17 |
CN100531767C true CN100531767C (en) | 2009-08-26 |
Family
ID=37608215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610047077XA Expired - Fee Related CN100531767C (en) | 2006-06-29 | 2006-06-29 | Capsules for treating prostatauxe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100531767C (en) |
-
2006
- 2006-06-29 CN CNB200610047077XA patent/CN100531767C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1895474A (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101152495A (en) | Traditional Chinese medicine for treating chronic appendicitis | |
CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
CN101214357A (en) | Pharmaceutical composition for treating chronic prostatitis | |
CN100579562C (en) | Oral Chinese medicine composition for treating constipation | |
CN101618129B (en) | Chinese medical preparation for treating rheumatoid osteopathia | |
CN1251748C (en) | Lotion for treating gynecological disease and its preparation process | |
CN101628096B (en) | Traditional Chinese medicine composition for treating infantile diarrhea | |
CN100531767C (en) | Capsules for treating prostatauxe | |
CN1876088A (en) | A medicine for treating chronic prostatitis and preparation method thereof | |
CN103611050B (en) | A pharmaceutical composition for intestinal tract cleaning | |
CN103768478A (en) | Traditional Chinese medicine composition for treating prostatitis and preparation method and application thereof | |
CN101623457B (en) | Traditional Chinese medicine for treating chronic prostatitis | |
CN101653582B (en) | Medicine for curing nephrolithiasis | |
CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
CN103599281B (en) | Traditional Chinese medicinal composition for treating obsessive-compulsive disorder and application thereof | |
CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
CN101618187A (en) | Medicine for treating liver cancer and preparation method thereof | |
CN102302639B (en) | Traditional Chinese medicine composition for treating retention of urine | |
CN101259196B (en) | Chinese medicinal composition for treating gastric ulcer | |
CN100408078C (en) | Medicinal composition for treating hyperplasia of prostate and its preparing method | |
CN1424104A (en) | Medicines for treating chronic prostatitis and preparation thereof | |
CN104740529A (en) | Traditional Chinese medicine enema prescription for treating pelvic inflammation | |
CN102626479A (en) | External-use Chinese herbal medicine composition for chronic rheumatism treatment | |
CN101439110B (en) | Chinese medicine for curing rheumatism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090826 Termination date: 20100629 |